MoneyWorks4Me

Alivus Life Sciences - Quaterly Results

15 May 2025 Evaluate
The March 2025 quarter revenue stood at Rs. 6495.45 millions, up 21.05% as compared to Rs. 5365.97 millions during the corresponding quarter last year.The company has announced a 44.86% increase in its profits to Rs . 1418.68  millions for the  quarter ended March 2025 compared to Rs. 979.37 millions in the corresponding quarter in the previous year.The company reported a good operating profit of 2085.20 millions compared to 1445.77 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 6495.45 5365.97 21.05 23868.84 22832.14 4.54 23868.84 22832.14 4.54
Other Income 100.88 31.31 222.20 345.70 120.42 187.08 345.70 120.42 187.08
PBIDT 2085.20 1445.77 44.23 7171.54 6862.88 4.50 7171.54 6862.88 4.50
Interest 12.60 3.64 246.15 24.14 15.46 56.14 24.14 15.46 56.14
PBDT 2072.60 1442.13 43.72 7147.40 6847.42 4.38 7147.40 6847.42 4.38
Depreciation 159.70 145.34 9.88 606.09 534.52 13.39 606.09 534.52 13.39
PBT 1912.90 1296.79 47.51 6541.31 6312.90 3.62 6541.31 6312.90 3.62
TAX 494.22 317.42 55.70 1685.04 1604.02 5.05 1685.04 1604.02 5.05
Deferred Tax 15.45 6.88 124.56 60.64 81.88 -25.94 60.64 81.88 -25.94
PAT 1418.68 979.37 44.86 4856.27 4708.88 3.13 4856.27 4708.88 3.13
Equity 245.07 245.05 0.01 245.07 245.05 0.01 245.07 245.05 0.01
PBIDTM(%) 32.10 26.94 19.15 30.05 30.06 -0.04 30.05 30.06 -0.04
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..